Related Experiment Video

Updated: Nov 19, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.6K

Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients

Melanie Dubois1,2, Avika Dixit1,2, Gabriella Lamb1,2

  • 1Boston Children's Hospital, Boston, MA, USA.

Global Pediatric Health
|January 28, 2021
PubMed

Insights

Pediatric solid organ and stem cell transplant recipients face high risks from tuberculosis (TB). Managing TB in these children is complex due to immunosuppression and drug interactions, requiring further research for better outcomes.

Area of Science:

  • Pediatric medicine
  • Infectious diseases
  • Transplantation immunology

Background:

  • Children undergoing transplantation are highly susceptible to tuberculosis (TB).
  • Post-transplant TB presents significant morbidity and mortality risks.
  • Management is complicated by immunosuppression and potential drug interactions.

Purpose of the Study:

  • To review the current understanding of TB in pediatric transplant recipients.
  • To address the unique challenges in managing TB in this population.
  • To consolidate information on epidemiology, diagnosis, treatment, and prevention.

Main Methods:

  • Literature review of existing studies and clinical data.
  • Synthesis of current knowledge on TB in pediatric transplant patients.
  • Analysis of challenges specific to immunosuppressed pediatric populations.

Main Results:

  • TB poses a substantial threat to pediatric transplant recipients.
  • Limited data exist on the specific management of TB in this group.
  • Key challenges include diagnosis, treatment efficacy, and drug interactions.

Conclusions:

  • Pediatric transplant recipients with TB require specialized care.
  • Further research is essential to enhance diagnostic accuracy.
  • Optimizing treatment strategies is crucial for improving patient outcomes.

Keywords:
hematopoietic stem cell transplantpediatric tuberculosissolid organ transplant

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.1K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.5K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
507
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
323
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
286
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
638
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
887
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
606